DK1623740T3 - Farmaceutisk sammensætning og metode til behandling af og forebyggelse mod prostatahyperplasi og prostatitis under anvendelse af frugter og Roystonea regis (kongepalme) - Google Patents

Farmaceutisk sammensætning og metode til behandling af og forebyggelse mod prostatahyperplasi og prostatitis under anvendelse af frugter og Roystonea regis (kongepalme)

Info

Publication number
DK1623740T3
DK1623740T3 DK04720576T DK04720576T DK1623740T3 DK 1623740 T3 DK1623740 T3 DK 1623740T3 DK 04720576 T DK04720576 T DK 04720576T DK 04720576 T DK04720576 T DK 04720576T DK 1623740 T3 DK1623740 T3 DK 1623740T3
Authority
DK
Denmark
Prior art keywords
fruits
carbon atoms
prostatitis
pharmaceutical composition
roystonea
Prior art date
Application number
DK04720576T
Other languages
Danish (da)
English (en)
Inventor
Granja Abilio M Laguna
Leyes Eduardo A Rodriguez
Ferreiro Rosa M Mas
Quintana Daisy Carbajal
Canavaciolo Victor L Gonzalez
Valmana Arruzazabala
Cuevas Vivian Molina
Original Assignee
Dalmer Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40210497&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1623740(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dalmer Lab Sa filed Critical Dalmer Lab Sa
Application granted granted Critical
Publication of DK1623740T3 publication Critical patent/DK1623740T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/889Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK04720576T 2003-03-20 2004-03-15 Farmaceutisk sammensætning og metode til behandling af og forebyggelse mod prostatahyperplasi og prostatitis under anvendelse af frugter og Roystonea regis (kongepalme) DK1623740T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20030062A CU23256A1 (es) 2003-03-20 2003-03-20 EXTRACTO OBTENIDO A PARTIR DE FRUTOS DE ROYSTONEA REGIA UTILIZADO CONTRA LA HIPERPLASIA PROSTáTICA Y LA PROSTATITIS
PCT/CU2004/000004 WO2004082696A1 (es) 2003-03-20 2004-03-15 Composición farmacéutica y procedimiento para el tratamiento y prevención de la hiperplasia prostática y la prostatitis a partir de los frutos de roystones regia (palma real)

Publications (1)

Publication Number Publication Date
DK1623740T3 true DK1623740T3 (da) 2008-09-08

Family

ID=40210497

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04720576T DK1623740T3 (da) 2003-03-20 2004-03-15 Farmaceutisk sammensætning og metode til behandling af og forebyggelse mod prostatahyperplasi og prostatitis under anvendelse af frugter og Roystonea regis (kongepalme)

Country Status (24)

Country Link
US (3) US20060228429A1 (enExample)
EP (1) EP1623740B1 (enExample)
JP (1) JP4693766B2 (enExample)
KR (1) KR100758256B1 (enExample)
CN (1) CN100366246C (enExample)
AT (1) ATE394139T1 (enExample)
AU (1) AU2004222693B2 (enExample)
BR (1) BRPI0409056A (enExample)
CA (1) CA2519410C (enExample)
CR (1) CR8001A (enExample)
CU (1) CU23256A1 (enExample)
DE (1) DE602004013572D1 (enExample)
DK (1) DK1623740T3 (enExample)
EC (1) ECSP056028A (enExample)
ES (1) ES2306999T3 (enExample)
IL (1) IL170997A (enExample)
MX (1) MXPA05009905A (enExample)
NO (1) NO333290B1 (enExample)
NZ (1) NZ542361A (enExample)
PT (1) PT1623740E (enExample)
RU (1) RU2331434C2 (enExample)
UA (1) UA82224C2 (enExample)
WO (1) WO2004082696A1 (enExample)
ZA (1) ZA200507575B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4926395B2 (ja) * 2004-11-30 2012-05-09 学校法人 名城大学 抗mrsa用組成物
KR100769412B1 (ko) * 2006-09-13 2007-10-22 주식회사 벤스랩 Pr-119 복합생약 추출물을 함유하는 전립선 비대증의예방 및 치료용조성물
WO2010118362A1 (en) 2009-04-09 2010-10-14 The Regents Of The University Of Colorado, A Body Corporate Methods and compositions for inducing physiological hypertrophy
CU24143B1 (es) * 2012-06-19 2016-01-29 Cnic Ct Nac Investigaciones Ingrediente activo para el tratamiento y la prevención de la inflamación y el estrés oxidativo, así como su procedimiento de obtención a partir de los frutos de acrocomina crispa y/o acrocomia aculeata
CA2957363C (en) * 2014-08-12 2022-06-21 Institut de Recherche en Semiochimie et Ethologie Appliquee Palmitoleic acid for use in inhibiting the attachment of sea lice to fish
KR102273967B1 (ko) * 2014-10-31 2021-07-08 (주)아모레퍼시픽 인삼씨유를 함유하여 전립선 비대증을 예방 및 치료하는 조성물
JP2017214342A (ja) * 2016-06-02 2017-12-07 日清オイリオグループ株式会社 排尿障害の予防用又は改善用組成物
JP6628946B2 (ja) 2017-12-26 2020-01-15 大太朗 福岡 増毛、頭皮若しくは皮膚の改質、創傷治癒、骨形成促進、または毛髪の改質に用いるための医薬組成物
AU2019212513B2 (en) 2018-01-26 2024-10-31 Fluidx Medical Technology, Llc Apparatus and method of using in situ solidifying complex coacervates for vascular occlusion
EP4082518A1 (en) 2021-04-28 2022-11-02 Cnce Innovacion, S.L. Fatty acid compositions for the treatment and prevention of hair loss and alopecia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU21519A1 (en) * 1983-03-23 1987-06-09 Inst De Quimica Y Biolog Ex Procedure to facilitate the grinding of roystonea regia fruits
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones
CN1184670A (zh) * 1997-12-23 1998-06-17 张冰 一种治疗前列腺增生、前列腺炎的药物组合物
RU2140265C1 (ru) * 1998-10-27 1999-10-27 Чернобаев Николай Евгеньевич Средство для лечения и профилактики доброкачественной гиперплазии простаты (дгп), простатита, импотенции, бесплодия и рака предстательной железы

Also Published As

Publication number Publication date
RU2005130746A (ru) 2006-06-10
ECSP056028A (es) 2006-01-27
DE602004013572D1 (de) 2008-06-19
CN100366246C (zh) 2008-02-06
AU2004222693B2 (en) 2010-08-12
US20100022649A1 (en) 2010-01-28
HK1084059A1 (en) 2006-07-21
KR20050115920A (ko) 2005-12-08
ATE394139T1 (de) 2008-05-15
MXPA05009905A (es) 2006-03-21
UA82224C2 (uk) 2008-03-25
CA2519410A1 (en) 2004-09-30
JP2006520331A (ja) 2006-09-07
US20100021574A1 (en) 2010-01-28
CU23256A1 (es) 2008-01-24
KR100758256B1 (ko) 2007-09-13
AU2004222693A2 (en) 2004-09-30
NO20054847L (no) 2005-10-20
IL170997A (en) 2010-04-15
EP1623740A1 (en) 2006-02-08
PT1623740E (pt) 2008-08-12
ES2306999T3 (es) 2008-11-16
CN1761476A (zh) 2006-04-19
US20060228429A1 (en) 2006-10-12
CA2519410C (en) 2011-04-26
BRPI0409056A (pt) 2006-03-28
EP1623740B1 (en) 2008-05-07
JP4693766B2 (ja) 2011-06-01
CR8001A (es) 2006-04-21
ZA200507575B (en) 2007-03-28
WO2004082696A1 (es) 2004-09-30
NO333290B1 (no) 2013-04-29
NZ542361A (en) 2009-10-30
AU2004222693A1 (en) 2004-09-30
RU2331434C2 (ru) 2008-08-20

Similar Documents

Publication Publication Date Title
DK1623740T3 (da) Farmaceutisk sammensætning og metode til behandling af og forebyggelse mod prostatahyperplasi og prostatitis under anvendelse af frugter og Roystonea regis (kongepalme)
BR0013011A (pt) Processo e aparelho para preparar extratos e óleos de plantas e de outras matérias
DK1019060T3 (da) Androgensynteseinhibitorer
TW200502029A (en) Composition and process
DK1000181T3 (da) Fremgangsmåde til behandling af austenitiske rustfrie stålartikler
DE60001346D1 (de) Verfahren zur Herstellung von Form II Kristallen des Clarithromycins
ATE472590T1 (de) Vorrichtung zur erzeugung eines brennbaren gasgemisches
DE59401321D1 (de) Verfahren zur Gewinnung von pharmakologisch wirksamen Verbindungen aus komplexen Stoffgemischen
NO20044333L (no) Farmasoytiske kombinasjon for behandling av godartet prostatis hyperplasi eller for langtidsprevensjon av akutt urinretensjon
BRPI0512665A (pt) processo aprimorado para a extração por solvente de polihidroxialcanoatos de biomassa
ES2155746A1 (es) Procedimiento y aparato para la produccion de carbon activo.
ATE519859T1 (de) Verfahren zur herstellung von ausgewählten intermolekularen quervernetzungen in nukleinsäuren und ihre verwendungen
UA56965U (ru) Средство для лечения и профилактики доброкачественной гиперплазии предстательной железы, простатита, импотенции, бесплодия и paka предстательной железы
DE59206391D1 (de) Vorrichtung zur thermischen behandlung von lockerem gut
ATE257842T1 (de) Verfahren zur gewinnung von 17beta-(n-tert- butylcarbamoyl)-3-on-4-aza-steroiden
BR9910953A (pt) Processo para fabricar um produto carboxilatode terra rara sólido e método para melhorar asolubilidade do mesmo
Aronov Practical application of intensive quenching technology for steel parts
ATE292526T1 (de) Verfahren zur entfernung von verunreinigungen aus feuchten böden
Board Studies towards the total synthesis of Lactonamycin
KR20030011136A (ko) 건설 폐기물 처리 방법
Kurits Investigation of the combined strengthening effect on the stressed state of cylindrical sample(as a model of shaft-type part)
JPS5510307A (en) Removing method of cross gate of casting
JPS52119490A (en) Exhaust gas treating agent
DE59708998D1 (de) Verfahren zur Herstellung massiver Magnetkörper
Stratton et al. Gas quenching carburised components.